Moreover, laminarin represses the proliferation and metastasis of liver cancer cells via a reduction in endogenous hydrogen sulfide production and effects on the pSTAT3/BCL-2 and VEGF cascades, which include MMPs, VEGF, p-AKT, and p-ERK1/2 [23]. The gene discussed is AKT1; the disease is liver cancer.